As Mainers, we understand the importance of having guidance when a storm approaches. Just as a lighthouse helps boats navigate through rough seas, the 340B program enables safety-net providers (federally qualified health centers, rural hospitals, community pharmacies and others) to weather financial storms and provide affordable care to underserved communities.

For over 30 years, the 340B program has helped providers to purchase medication at discounted prices without relying on taxpayer funding. Pharmaceutical companies offer these discounts, which enable providers to stretch their budgets and fund essential services, such as dental care, mental health support and other community needs. For many Mainers, the 340B program is a lifeboat that helps keep them afloat instead of being left adrift due to high health care costs.

However, pharmaceutical companies continue to restrict access to these discounts, which puts safety-net providers at risk. LD 1018, which has bipartisan support, aims to ensure that rural and underserved communities can continue to receive affordable medications. The bill will prevent unfair restrictions and discrimination against Maine’s safety-net providers, which have resulted in millions of dollars in lost savings. Without the 340B program, providers could be forced to reduce staff, cut services, or even shut down altogether.

I strongly encourage Maine’s Legislature to protect the 340B program and hold pharmaceutical companies accountable. LD 1018 helps ensure that Maine’s safety-net providers are supported without being pushed adrift by corporate interests.

Leslie Lorentzen
Waldoboro